Literature DB >> 29250274

Prevention of Cardiac Implantable Electronic Device Infections: Update and Evaluation of the Potential Role for Capsulectomy or the Antibiotic Pouch.

Marye J Gleva1, Jeanne E Poole2.   

Abstract

Cardiac implantable electronic device (CIED) infections can have devastating implications for patient morbidity and mortality. Over the past decade, the infection rate has risen out of proportion to implant rates, and has prompted the development of innovative solutions designed to reduce infections. The first section of this review provides a summary of the contemporary knowledge regarding the incidence, prevalence, microbiology, and risk factors for cardiac implantable electronic device infections. The second section addresses prevention with an emphasis on the potential role of novel procedural approaches, such as capsulectomy and the antibacterial envelope, in reducing CIED infection.

Entities:  

Keywords:  Antibacterial envelope; Capsulectomy; Cardiac implantable electronic device ; Infection

Year:  2017        PMID: 29250274      PMCID: PMC5673390          DOI: 10.4022/jafib.1540

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  34 in total

1.  Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee.

Authors:  A J Mangram; T C Horan; M L Pearson; L C Silver; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1999-04       Impact factor: 3.254

2.  Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.

Authors:  Daniel Z Uslan; Marye J Gleva; David K Warren; Theofanie Mela; Mina K Chung; Venkateshwar Gottipaty; Richard Borge; Dan Dan; Timothy Shinn; Kevin Mitchell; Richard G Holcomb; Jeanne E Poole
Journal:  Pacing Clin Electrophysiol       Date:  2011-11-11       Impact factor: 1.976

Review 3.  A review of the current status of pericardial closure following cardiac surgery.

Authors:  W Douglas Boyd; John V Tyberg; James L Cox
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-09

4.  Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.

Authors:  Suneet Mittal; Richard E Shaw; Kimberly Michel; Rachel Palekar; Aysha Arshad; Dan Musat; Mark Preminger; Tina Sichrovsky; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2013-12-10       Impact factor: 6.343

5.  Prophylactic antibiotics and the insertion of permanent transvenous cardiac pacemakers.

Authors:  A I Hartstein; J Jackson; D N Gilbert
Journal:  J Thorac Cardiovasc Surg       Date:  1978-02       Impact factor: 5.209

6.  Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.

Authors:  Vidal Essebag; Atul Verma; Jeff S Healey; Andrew D Krahn; Eli Kalfon; Benoit Coutu; Felix Ayala-Paredes; Anthony S Tang; John Sapp; Marcio Sturmer; Arieh Keren; George A Wells; David H Birnie
Journal:  J Am Coll Cardiol       Date:  2016-03-22       Impact factor: 24.094

7.  Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.

Authors:  Heather L Bloom; Luis Constantin; Daniel Dan; David B De Lurgio; Mikhail El-Chami; Leonard I Ganz; Kent J Gleed; F Kevin Hackett; Narendra K Kanuru; Daniel J Lerner; Abdi Rasekh; Grant R Simons; Felix O Sogade; Muhammad R Sohail
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-13       Impact factor: 1.976

8.  Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis.

Authors:  Rabih O Darouiche; Matthew J Wall; Kamal M F Itani; Mary F Otterson; Alexandra L Webb; Matthew M Carrick; Harold J Miller; Samir S Awad; Cynthia T Crosby; Michael C Mosier; Atef Alsharif; David H Berger
Journal:  N Engl J Med       Date:  2010-01-07       Impact factor: 91.245

9.  Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.

Authors:  Jordan M Prutkin; Matthew R Reynolds; Haikun Bao; Jeptha P Curtis; Sana M Al-Khatib; Saurabh Aggarwal; Daniel Z Uslan
Journal:  Circulation       Date:  2014-07-31       Impact factor: 29.690

10.  The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.

Authors:  Mohammed Qintar; Omeed Zardkoohi; Muhammad Hammadah; Amy Hsu; Oussama Wazni; Bruce L Wilkoff; Khaldoun G Tarakji
Journal:  Pacing Clin Electrophysiol       Date:  2014-09-16       Impact factor: 1.976

View more
  3 in total

Review 1.  Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.

Authors:  Kun Xiang; John N Catanzaro; Claude Elayi; Zerelda Esquer Garrigos; Muhammad R Sohail
Journal:  Cureus       Date:  2021-02-02

2.  Use of Biologic Extracellular Matrix in Two Ways to Reduce Cardiac Electronic Device Infection.

Authors:  Emily Buchanan; Dale Yoo
Journal:  Cureus       Date:  2021-01-31

Review 3.  Antibiotic-Eluting Envelopes for the Prevention of Cardiac Implantable Electronic Device Infections: Rationale, Efficacy, and Cost-Effectiveness.

Authors:  Vassil Traykov; Carina Blomström-Lundqvist
Journal:  Front Cardiovasc Med       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.